Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001754831 | SCV001996451 | uncertain significance | not provided | 2019-09-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function |
Labcorp Genetics |
RCV003771983 | SCV003790512 | likely benign | Cutis laxa, autosomal dominant 3; Autosomal dominant spastic paraplegia type 9; de Barsy syndrome | 2024-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003247013 | SCV003944003 | uncertain significance | Inborn genetic diseases | 2023-06-07 | criteria provided, single submitter | clinical testing | The c.1172A>G (p.H391R) alteration is located in exon 11 (coding exon 10) of the ALDH18A1 gene. This alteration results from a A to G substitution at nucleotide position 1172, causing the histidine (H) at amino acid position 391 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |